Temporal and tissue-specific expression of kallikrein (Klk) genes and identification of a novel Klk messenger ribonucleic acid transcript during early development in the mouse

Biology of Reproduction

Volumn 61, Issue 3, 1999, Pages 621-628

  Chan, Carolyn S ^a   Harvey, Mark B ^a   Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; KALLIKREIN; MESSENGER RNA; NERVE GROWTH FACTOR; TISSUE KALLIKREIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; DECIDUA; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; MOUSE; MULTIGENE FAMILY; NIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA TRANSCRIPTION; SOUTHERN BLOTTING; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLASTOCYST; BLOTTING, SOUTHERN; DECIDUA; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENE EXPRESSION; KALLIKREINS; MICE; MOLECULAR SEQUENCE DATA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERUS;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0032780283     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod61.3.621     Document Type: Article

References (49)

1. Graham CH, Lala PK. Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol 1992; 70:867-874.
2. Bischof P, Campana A. A model for implantation of the human blastocyst and early implantation. Hum Reprod Update 1996; 2:262-270.
3. Berendtsen O, Alexander C, Werb Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 1992; 114:447-456.
4. Harvey M, Leco K, Arcenella-Panlilio M, Zhang X, Edwards D, Schultz G. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 1995; 121:1005-1014.
5. Librach C, Werb Z, Fitzgerald M, Chiu K, Corwin N, Esteves R, Grobelny D, Galardy R, Damsky C, Fisher S. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437-449.
6. Zhang X, Shu MA, Harvey MB, Schultz GA. Regulation of urokinase plasminogen activation production in implanting mouse embryo: effect of embryo interaction with extracellular matrix. Biol Reprod 1996; 54:1052-1058.
7. Kaye P, Harvey M. The role of growth factors in preimplantation development. Prog Growth Factor Res 1995; 6:1-24.
8. Chard T. Cytokines in implantation. Hum Reprod Update 1995; 1: 385-396.
9. McMaster MT, Dey SK, Andrews GK. Association of monocytes and neutrophils with early events of blastocyst implantation in mice. J Reprod Fertil 1993; 99:561-569.
10. Clements J, Mukhtar A. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Cliln Endocrinol Metab 1994; 78:1536-1539.
11. Clements J, Mukhtar A, Ehrlich A, Yap B. Glandular kallikrein gene expression in the human uterus. Braz J Med Biol Res 1994; 27:1855-1863.
12. Corthorn J, Valdes G. Variations in uterine kallikrein during cycle and early pregnancy in the rat. Biol Reprod 1994; 50:1261-1264.
13. Corthorn J, Figueroa C, Valdes G. Estrogen and luminal stimulation of rat uterine kallikrein. Biol Reprod 1997; 56:1432-1438.
14. Valdes G, Figueroa C, Corthorn J. Temporospatial changes of kallikrein-like enzymes during the estrous cycle and pregnancy in the rat uterus. Biol Reprod 1996; 55:236-245.
15. Clements J. The molecular biology of the kallikreins and their roles in inflammation. In: Farmer S (ed.), The Kinin System. Great Britain: Academic Press; 1997: 71-97.
16. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kinases. Pharmacol Rev 1992; 44:1-80.
17. Desrivieres S, Lu H, Peyri N, Soria C, Legrand Y, Menashi S. Activation of 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol 1993; 157:587-593.
18. Tschesche H, Michaelis J, Kohnert U, Fedrowitz Oberhoff R. Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol 1989; 247A:545-548.
19. Frenette G, Tremblay R, Lazure C, Dube J. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int J Cancer 1997; 71:897-899.
20. Wolf B, Brown M. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator. FEBS Lett 1995; 376:177-180.
21. Deperthes D, Frenette G, Brillard-Bourdet M, Bourgeois L, Gauthier F, Tremblay R, Dube J. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J Androl 1996; 17:659-665.
22. Menashi S, Fridman R, Desrivieres S, Lu H, Legrand Y, Soria C. Regulation of 92-kDA gelatinase activity in the extracellular matrix by tissue kallikrein. Ann N Y Acad Sci 1994; 732:466-468.
23. Webber M, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1995; 1:1089-1094.
24. Drinkwater C, Evans B, Richards R. Mouse glandular kallikrein genes: identification and characterization of the genes encoding the epidermal growth factor binding protein. Biochemistry 1987; 26: 6750-6756.
25. Drinkwater C, Evans B, Richards R. Kallikreins, kinins and growth factor biosynthesis. TIBS 1988; 13:169-172.
26. Cohen P, Graves HCB, Peehl DM, Kamarei M, Guidice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992; 75:1046-1053.
27. Finn CA. Implantation, menstruation and inflammation. Biol Rev 1986; 61:313-328.
28. Valdes G, Corthorn J, Scicli A, Gaete V, Soto J, Ortiz M, Foradori A, Saed G. Uterine kallikrein in the early pregnant rat. Biol Reprod 1993; 49:802-808.
29. Digby M. A comparison of human and mouse tissue kallikrein gene families. Melbourne, Australia: University of Melbourne; 1991. Thesis.
30. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full-length sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 1986; 14: 2829.
31. Evans B, Drinkwater C, Richards R. Mouse glandular kallikrein genes: structure and partial sequence analysis of the kallikrein gene locus. J Biol Chem 1987; 262:8027-8034.
32. Wines DR, Brady JM, Southard EM, MacDonald RJ. Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity. J Mol Evol 1991; 32:476-492.
33. Neurath H. Evolution of proteolytic enzymes. Science 1984; 224:350-357.
34. Merriman JA, Whittingham DG, Carroll J. The effect of follicle stimulating hormone and epidermal growth factor on the developmental capacity of in-vitro matured mouse oocytes. Hum Reprod 1998; 13: 690-695.
35. Paria BC, Dey SK. Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. Proc Natl Acad Sci USA 1990; 87:4756-4760.
36. Huet-Hudson YM, Chakraborty C, Dey SK, Suzuki Y, Andrews GK, Dey SK. Estrogen upregulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol Endocrinol 1990; 4:510-523.
37. Bany BM, Zhang XQ, Kennedy TG. Effects of epidermal growth factor and interleukin-1-alpha on plasminogen activator secretion and decidualization in rat endometrial stromal cells. Biol Reprod 1998; 59:131-135.
38. 2. Biol Reprod 1996; 54:1046-1051.
39. Werb Z. Expression of EGF and TGF-alpha genes in early mammalian development. Mol Reprod Dev 1990; 27:10-15.
40. Uddin M, Beg OU. Cleavage specificities of individual members of kallikrein family of proteins on synthetic peptide containing the bradykinin sequence. J Protein Chem 1998; 17:291-294.
41. Wang MH, Gonias SL, Skeel A, Wolff BB, Yoshimura T, Leonard EJ. Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein gene family. J Biol Chem 1994; 269:13806-13810.
42. el-Dahr SS. Ontogeny of the intrarenal kallikrein-kinin system: proposed role in renal development. Microsc Res Tech 1997; 39:222-232.
43. Guillomot M, Flechon J, Leroy F. Blastocyst development and implantation. In: Thibault C, Levasseur MC (eds.), Reproduction in Mammals and Man. Paris: Ellipses; 1993: 387-410.
44. Lerner UH. The role of the kallikrein-kinin system in inflammationinduced bone metabolism. In: Farmer S (ed.), The Kinin System. Great Britain: Academic Press; 1997: 219-234.
45. Maggi CA. Bradykinin as an inflammatory mediator in the urinary tract. In: Farmer S (ed.), The Kinin System. Great Britain: Academic Press; 1997: 235-248.
46. Figueroa CD, Novoa U, Valdes G, Corthorn J, Müller-Ersterl W. Localisation of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells, Immunopharmacology 1997; 35:127-133.
47. Rehbock J, Chondromatidou A, Miska K, Buchinger P, Hermann A. Evidence for bradykinin B2 receptors on cultured human decidua cells. Immunopharmacology 1997; 35:135-141.
48. Rehbock J, Chondromatidou A, Buchinger P, Hermann A, Jochum M. Bradykinin stimulates interleukin-6 and interleukin-8 secretion of human decidua derived cells. Br J Obstet Gynaecol 1997; 104:495-499.
49. Schrey M, Holt J, Cornford P, Monaghan H, al-Ubaidi F. Human decidua is a target for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro. J Clin Endocrinol Metab 1992; 74:426-435.